Zoledronate T29581+Solinj+BM


Indications and Reactions:

Role Indications Reactions
Primary
Metastases To Bone 43.2%
Breast Cancer 23.5%
Bone Sarcoma 9.5%
Prostate Cancer 7.6%
Non-small Cell Lung Cancer 2.5%
Prophylaxis 2.5%
Hypertension 2.2%
Antiemetic Supportive Care 1.6%
Depression 1.6%
Asthma 0.6%
Chemotherapy 0.6%
Hiatus Hernia 0.6%
Hypocalcaemia 0.6%
Nausea 0.6%
Prostate Cancer Metastatic 0.6%
Sedation 0.6%
Anxiety 0.3%
Arthritis 0.3%
Blood Cholesterol 0.3%
Blood Pressure 0.3%
Tooth Extraction 28.6%
Osteonecrosis 13.5%
Vomiting 7.5%
Swelling 6.8%
Osteonecrosis Of Jaw 6.0%
Toothache 5.3%
Pain In Jaw 3.8%
Renal Impairment 3.0%
White Blood Cell Count Decreased 3.0%
Wound Treatment 3.0%
Diverticulitis 2.3%
Pain 2.3%
Pyrexia 2.3%
Renal Tubular Disorder 2.3%
Sepsis 2.3%
Vision Blurred 2.3%
Erysipelas 1.5%
Hypocalcaemia 1.5%
Necrosis 1.5%
Neuralgia 1.5%
Secondary
Metastases To Bone 45.7%
Bone Sarcoma 25.7%
Breast Cancer 11.4%
Prostate Cancer Metastatic 11.4%
Prostate Cancer 5.7%
Tooth Extraction 17.2%
Swelling 13.8%
Vision Blurred 10.3%
Joint Stiffness 6.9%
Osteonecrosis 6.9%
Pain In Extremity 6.9%
Terminal State 6.9%
Urinary Tract Infection 6.9%
Pain In Jaw 3.4%
Spinal Osteoarthritis 3.4%
Staphylococcal Infection 3.4%
Tooth Infection 3.4%
Toxic Encephalopathy 3.4%
Transient Ischaemic Attack 3.4%
Wound Closure 3.4%

Drug Data